Outset Medical Reports Q1 Results with Record Gross Margin and Reduced Net Loss

summarizeSummary

Outset Medical, Inc. reported first-quarter 2026 financial results, highlighting a record gross margin of 43.4% and a significant reduction in net loss, alongside a strong cash position and reiterated full-year guidance.

check_boxKey Events

• Record Gross Margin Achieved

  Gross margin expanded by over 600 basis points to a record 43.4% (43.8% non-GAAP), driven by strong product and service gross margins.

• Net Loss Significantly Reduced

  Net loss decreased to $19.0 million from $25.8 million in the prior-year period, reflecting improved operational efficiency.

• Strong Cash Position and Reduced Cash Burn

  The company ended the quarter with $161 million in cash, cash equivalents, and short-term investments, with net cash used of $12 million, less than previously forecasted.

• Revenue Decline and Reaffirmed Guidance

  Net revenue decreased 6% to $27.9 million, but the company reiterated its full-year 2026 revenue guidance of $125 million to $130 million and non-GAAP gross margin guidance.

auto_awesomeAnalysis

Despite a 6% decline in net revenue, Outset Medical demonstrated strong operational execution by expanding its gross margin by over 600 basis points to a record 43.4%. The company also significantly reduced its net loss and managed cash burn better than forecasted, ending the quarter with a robust $161 million in cash. These improvements in profitability and cash management are critical for a company of this size and indicate progress towards its path to profitability, reinforcing investor confidence in its reiterated full-year guidance.